LysoPC(18:0/0:0)
|
Basic information |
| Metabolite name | LysoPC(18:0/0:0) |
 | HMDB0010384 |
 |
C04230 |
 |
497299 |
| Synonyms | 1-Stearoyl-sn-glycerol 3-phosphocholine; |
| No. of studies | 8 |
|
Basic information |
| Metabolite name | LysoPC(18:0/0:0) |
| HMDB0010384 |
|
C04230 |
|
497299 |
| Synonyms | 1-Stearoyl-sn-glycerol 3-phosphocholine; |
| No. of studies | 8 |
|
Relationship between LysoPC(18:0/0:0) and depression (count: 8) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M1097 | Type1 | placebo-treated depression group vs. control group | Faece | Human | Up |
| Study M460 | Type1 | depressed group vs. control group | Liver | Kunming mouse | Up |
| Study M578 | Type1 | restraint stress offspring group vs. control offspring group | Hippocampus | Sprague-Dawley rat | Down |
| Study M609 | Type1 | LPS group vs. control group | Hippocampus | Sprague-Dawley rat | Up |
| Study M769 | Type1 | CSDS group vs. control group | Amygdala | Sprague-Dawley rat | Down |
| Study M772 | Type1 | CUMS group vs. control group | Amygdala | Sprague-Dawley rat | Down |
| Study M942 | Type1 | CUMS group vs. control group | Serum | C57BL/6 mouse | Up |
| Study M942 | Type2 | CUMS + berberine group vs. CUMS group | Serum | C57BL/6 mouse | Down |
| Study M981 | Type2 | Abeta oligomer + acousto-optic stimulation group vs. Abeta oligomer group | Serum | ICR mouse | Up |